Bio-Rad debuts guide to improve access to COVID-19 tests

2019 08 20 21 56 5455 Bio Rad Aacc 2019 400

Bio-Rad Laboratories has launched a standard for SARS-CoV-2 to help labs validate assays and speed up access to testing for COVID-19 novel coronavirus disease.

The standard contains synthetic COVID-19 RNA transcripts and human genomic DNA, allowing laboratories to test the process of a molecular assay, including extraction, amplification, and detection of the virus. These specifications also enable more laboratories to meet the growing demand of identifying those infected with the coronavirus, according to Bio-Rad.

The CLIA federal regulatory standards require clinical laboratories to establish and document their performance specifications for laboratory-developed tests to ensure accurate and precise results prior to implementation.

Page 1 of 68
Next Page